Clinical Trial Update: Japanese Phase 1 Study of GSK2585823 [Phase 1]

View source ↗

Summary

GlaxoSmithKline's GSK2585823 completed a Japanese Phase 1 trial for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• GSK2585823

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED